Fundamental Analysis of Amgen Inc - Growth / Value Index
AMGN - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.422
Book Value in last 3 years is trending up
Tsr Value Index - Very Poor Score of 17.19
Price to Book Ratio of 26.98 suggesting that it is very expensive
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 44.65 | 22.22 | -13.88 % | |
| Price to Book | 27.07 | 26.98 | -41.58 % | 33.35 |
| Price to Sales | 5.70 | 6.27 | -2.44 % | |
| Enterprise Value to EBITDA Multiple | 21.92 | 16.26 | -28.96 % |
AMGN - Profitability Highlights
Profitability Analysis
Piotroski F Score - Good Value of 7.0
Excellent Net Margin for last 3 years
Company Earning excess return
During the past twelve months, the company has given a strong Return On Equity of 60.62%
Annual Net Profit in last 3 years is trending up
Good Return On Capital Employed of 10.68
Good Net Margin of 12.76% is achieved by the company
Tsr Profitability Index - Poor Score of 29.38
Low Earning Yield of 2.25 %
EPS decline for last four quarters
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 60.62 | 121.41 | -32.16 % | -2.25 |
| Return On Asset | 4.09 | 7.79 | -22.60 % | -0.122 |
| Net Profit Margin | 12.76 | 28.20 | 13.28 % | -1.53 |
| Operating Profit Margin | 23.46 | 33.00 | -9.18 % | 12.71 |
| EBITDA Margin | 34.25 | 50.82 | 52.85 % | 31.63 |
Highlights
| Market Cap | 167619 M |
| Enterprise Value | 221288 M |
| Price/Book TTM | 27.07 |
| Outstanding Share | 536435 K |
| Float/ Outstanding Share | 99.71% |
| Dividend Yield | 2.86 % |
Share Holding
Guru Numbers
| Price/Graham No | 7.32 |
| Peter Lynch Ratio | 0.362 |
| Piotroski F Score | 7.00 |
| Altman Z Score | 1.47 |
| Sloan Ratio | 0.239 |
| Peter Lynch Fair Value | 0 |
AMGN - Growth Highlights
Growth Analysis
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Very Poor Score of 15.14
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 29481.00 M | 1.94 % | 9.76 % |
| Gross Profit | 19550.00 M | 0.854 % | 17.47 % |
| EBITDA | 10097.00 M | 55.82 % | 23.39 % |
| Net Profit | 3763.00 M | 15.48 % | 114.73 % |
| EPS | 7.00 | 16.12 % | NA |
AMGN - Stability Highlights
Stability Analysis
Tsr Stability Index - Very Poor Score of 14.06
Altman Z Score of 1.47 suggest high risk
Company has high debt burden
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 10.37 | -2.54 % | 12.75 |
| Cash Ratio | 0.595 | 0.316 % | |
| Quick Ratio | 1.13 | 2.88 % | 0.979 |
| Shareholders Equity | 6.41 | 14.10 % | |
| Debt to EBITDA | 4.74 | 6.48 % |
Historical Valuation Ratios of Amgen Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Amgen Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Amgen Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Amgen Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)